Assessing programmed death ligand 1 (PD-L1) expression through immunohistochemistry (IHC) is the golden standard in predicting immunotherapy response of non-small cell lung cancer (NSCLC). However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results